CCND1 and breast cancer: Additionally, we observed that GSK126 treatment resulted in increased levels of CCND1 in the breast cancer line MDA-MB-231 and the SV40-immortalized monkey kidney fibroblast cell line COS7 (Fig. 6D), suggesting that PRC2 activity can repress CCND1 expression in multiple mammalian cell lineages and species.